116 related articles for article (PubMed ID: 34334300)
1. Coagulation and wound repair during COVID-19.
Menachery VD; Gralinski LE
J Heart Lung Transplant; 2021 Oct; 40(10):1076-1081. PubMed ID: 34334300
[TBL] [Abstract][Full Text] [Related]
2. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
3. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
Yamada S; Asakura H
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
[TBL] [Abstract][Full Text] [Related]
4. The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy.
Khezri MR; Varzandeh R; Ghasemnejad-Berenji M
Cell Mol Biol Lett; 2022 Jan; 27(1):6. PubMed ID: 35016612
[TBL] [Abstract][Full Text] [Related]
5. Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers.
Ebrahimi R; Nasri F; Kalantari T
Ann Hematol; 2024 Jun; 103(6):1819-1831. PubMed ID: 38349409
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease 2019-Associated Coagulopathy.
Lippi G; Sanchis-Gomar F; Favaloro EJ; Lavie CJ; Henry BM
Mayo Clin Proc; 2021 Jan; 96(1):203-217. PubMed ID: 33413819
[TBL] [Abstract][Full Text] [Related]
8. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
[TBL] [Abstract][Full Text] [Related]
9. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
[TBL] [Abstract][Full Text] [Related]
10. Multisystem Assessment of the Imaging Manifestations of Coagulopathy in Hospitalized Patients With Coronavirus Disease (COVID-19).
O'Shea A; Parakh A; Hedgire S; Lee SI
AJR Am J Roentgenol; 2021 Apr; 216(4):1088-1098. PubMed ID: 32755217
[No Abstract] [Full Text] [Related]
11. COVID-19-associated Coagulopathy.
Görlinger K; Levy JH
Anesthesiology; 2021 Mar; 134(3):366-369. PubMed ID: 33417671
[No Abstract] [Full Text] [Related]
12. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
13. Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.
Sayyadi M; Khosravi M; Ghaznavi-Rad E
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):518-522. PubMed ID: 33506943
[TBL] [Abstract][Full Text] [Related]
14. A proposal for the management of COVID-19-induced coagulopathy in adults.
Ignacio-Ibarra G; García-Lee MT; González-Ávila AI; García-Chávez J; Guzmán-Chores L; Cruz CL; Lugo-García Y; Juárez-Lara J; García-Vázquez M; Madera-Maldonado CE; Ramos-Peñafiel CO; Majluf-Cruz A
Gac Med Mex; 2021; 157(2):201-206. PubMed ID: 34270538
[TBL] [Abstract][Full Text] [Related]
15. Viscoelastic Tests in the Evaluation of Haemostasis Disturbances in SARS-CoV2 Infection.
Rodrigues A; Seara Sevivas T; Leal Pereira C; Caiado A; Robalo Nunes A
Acta Med Port; 2021 Jan; 34(1):44-55. PubMed ID: 33159728
[TBL] [Abstract][Full Text] [Related]
16. The most important biomarker associated with coagulation and inflammation among COVID-19 patients.
Hong LZ; Shou ZX; Zheng DM; Jin X
Mol Cell Biochem; 2021 Jul; 476(7):2877-2885. PubMed ID: 33742367
[TBL] [Abstract][Full Text] [Related]
17. Major coagulation disorders and parameters in COVID-19 patients.
Teimury A; Khameneh MT; Khaledi EM
Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
[TBL] [Abstract][Full Text] [Related]
18. Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis.
Zhang Y; He L; Chen H; Lu S; Xiong Y; Liu J; Zheng Y; Wang S; Liu L
Int J Lab Hematol; 2020 Dec; 42(6):766-772. PubMed ID: 32592539
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.
Meizoso JP; Moore HB; Moore EE
J Am Coll Surg; 2021 Jun; 232(6):995-1003. PubMed ID: 33766727
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Coagulopathy: From Pathogenesis to Treatment.
Alnima T; Mulder MMG; van Bussel BCT; Ten Cate H
Acta Haematol; 2022; 145(3):282-296. PubMed ID: 35499460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]